Cannabinoids enhance human B-cell growth at low nanomolar concentrations. (abst – 1995)                                  


Presence and functional regulation of cannabinoid receptors in immune cells. (abst – 1999) tplus


Cannabinoids, immune system and cytokine network.                    (abst – 2000)


Immunomodulation by Cannabinoids is Absent in Mice Deficient for the Cannabinoid Cb(2) Receptor.  (abst – 2000)


Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2- AG) in immune cells     (full – 2002)  cannabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=10&sortspec=relevance&resourcetype=H   WCIT


Endocannabinoids in the immune system and cancer.                   (abst – 2002)







Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells             (full – 2003)


The cannabinoid system and immune modulation               (full – 2003)


Cannabis May Suppress Immune System                 (news – 2003)


Cannabinoids and the immune system. Of men, mice and cells               (abst – 2004)


Cannabinoid receptors in microglia of the central nervous system: immune functional relevance.  (full – 2005)                     


Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders.                                                                  (full – 2005)


CB2 cannabinoid receptor agonist, JWH-015 triggers apoptosis in immune cells: Potential role for CB2 selective ligands as immunosuppressive agents                                                                  (full – 2006)


Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells (abst – 2006)                          


CB2 receptors in the brain: role in central immune function                (full – 2007)


Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors.     (full – 2007)


Targeting astrocytomas and invading immune cells with cannabinoids: a promising therapeutic avenue.   (abst – 2007)                         


Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain                                                                  (full – 2008)


Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases                                                               (full – 2008)


The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor.                                                                 (full – 2008)










Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.      (abst – 2008)                                  


Initial study of Hemp seeds protein on antifatigue and the immunomodulation effects in mice     (abst – 2008)            


Initial study of Hemp seeds protein on antifatigue and the immunomodulation effects in mice     (abst – 2008)            


Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis                                            (abst – 2008)


Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects       (full – 2009)          


Cannabinoids as novel anti-inflammatory drugs.              (full – 2009)


Cannabidiol-induced lymphopenia does not involve NKT and NK cells.            (full – 2009)


CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9- tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection.       (abst – 2009)


The morphology of the immune system in opiomania, cannabism, and polynarcotism (abst – 2009) he_immune_system_in_opiomania_cannabism_and_polynarcotism%5D


Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. (full – 2010)                         


Do cannabinoids have a therapeutic role in transplantation             (full – 2010)


Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties                                                              (full – 2010)


Cannabinoids and Viral Infections                (full – 2010)


Cannabinoids and the immune system: an overview.              (abst – 2010)









Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity.                                                    (abst – 2010)


Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol (full – 2011)


New blood brothers: the GPR55 and CB2 partnership             (full – 2011)


Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS. (full – 2011)                         


Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                        


CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura.         (full – 2011)


Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation (link to PDF– 2011)                                    


Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection.                                                         (abst – 2011)


Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis.                                             (abst – 2011)


Cannabis use and Cognitive Function: Eight Year Trajectory in a Young Adult Cohort. (abst – 2011)                           


Cannabinoid Receptor 2 Is Critical for the Homing and Retention of Marginal Zone B Lineage Cells and for Efficient T-Independent Immune Responses                                                   (abst – 2011)


Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells.                                                                  (abst – 2011)


The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease.          (abst – 2012)               


Review article: Mast cell–glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide                                                      (abst – 2012)









Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids.   (abst – 2012)                                  


Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Up- regulation of Serum IgE Levels in Immunized Mice.                                                                            (abst – 2012)


Cannabinoid receptor-2-selective agonists improve recovery in experimental autoimmune encephalomyelitis                                                    (abst – 2012)

=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resou  rcetype=HWCIT


Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis.                                                           (abst – 2012)


△9-Tetrahydrocannabinol Impairs the Inflammatory Response to Influenza Infection:

Role of Antigen Presenting Cells and the Cannabinoid Receptors 1 and 2.                  (abst – 2012)


Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120.  (abst – 2012)                        


Endocannabinoid modulation of jejunal afferent responses to LPS                     (abst – 2012)


Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington’s Disease.                                                          (abst – 2012)


Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2.                                                                   (abst – 2013)


Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt.                                                  (abst – 2013)

Share a link for